A detailed history of Versant Capital Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 484 shares of EW stock, worth $31,692. This represents 0.01% of its overall portfolio holdings.

Number of Shares
484
Previous 158 206.33%
Holding current value
$31,692
Previous $15,000 193.33%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$84.3 - $94.31 $27,481 - $30,745
326 Added 206.33%
484 $44,000
Q1 2024

Apr 03, 2024

BUY
$72.54 - $95.56 $8,124 - $10,702
112 Added 243.48%
158 $15,000
Q4 2023

Jan 08, 2024

BUY
$61.71 - $77.76 $617 - $777
10 Added 27.78%
46 $3,000
Q3 2023

Oct 11, 2023

SELL
$69.28 - $93.38 $207 - $280
-3 Reduced 7.69%
36 $2,000
Q2 2023

Jul 10, 2023

BUY
$81.41 - $94.33 $732 - $848
9 Added 30.0%
39 $3,000
Q4 2022

Jan 25, 2023

SELL
$68.3 - $87.44 $614 - $786
-9 Reduced 23.08%
30 $0
Q3 2022

Dec 30, 2022

SELL
$82.37 - $107.29 $1,317 - $1,716
-16 Reduced 29.09%
39 $3,000
Q1 2022

Apr 29, 2022

SELL
$101.96 - $128.34 $2,243 - $2,823
-22 Reduced 28.57%
55 $6,000
Q3 2021

Oct 29, 2021

SELL
$102.91 - $122.75 $1,646 - $1,964
-16 Reduced 17.2%
77 $9,000
Q2 2020

Jul 16, 2020

BUY
$57.54 - $76.95 $3,567 - $4,770
62 Added 200.0%
93 $6,000
Q1 2020

Apr 17, 2020

BUY
$52.41 - $81.0 $419 - $648
8 Added 34.78%
31 $5,000
Q2 2019

Jul 16, 2019

SELL
$55.74 - $64.41 $9,308 - $10,756
-167 Reduced 87.89%
23 $4,000
Q1 2019

Apr 23, 2019

BUY
$47.89 - $64.05 $7,375 - $9,863
154 Added 427.78%
190 $36,000
Q1 2019

Apr 23, 2019

SELL
$47.89 - $64.05 $7,375 - $9,863
-154 Reduced 81.05%
36 $36,000
Q3 2018

Oct 15, 2018

SELL
$45.7 - $58.03 $182 - $232
-4 Reduced 2.06%
190 $33,000
Q2 2017

Apr 23, 2018

SELL
N/A
-22 Reduced 10.19%
194 $22,000
Q3 2016

Apr 23, 2018

SELL
N/A
-7 Reduced 3.14%
216 $26,000
Q1 2016

Apr 23, 2018

BUY
N/A
17 Added 8.25%
223 $19,000
Q4 2015

Apr 23, 2018

BUY
N/A
206
206 $16,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.